Enliven Therapeutics to Present at Upcoming Investor Conferences
Enliven Therapeutics will engage investors at three major September 2026 healthcare conferences, including a webcasted Morgan Stanley fireside chat.
Rhea-AI Summary
Enliven Therapeutics (ELVN)/b) announced management participation in three September 2026 healthcare investor conferences hosted by Wells Fargo, Baird, and Morgan Stanley.The events take place in Boston on September 8 and in New York on September 15 and 16, featuring fireside chats and 1x1 meetings. A live webcast and 90-day replay of the Morgan Stanley fireside chat will be accessible via the company’s investor relations website.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Wells Fargo 21st Annual Healthcare Conference
Date: Tuesday, Sept. 8, 2026
Location:
Forum: 1x1 Meetings
Baird 2026 Global Healthcare Conference
Date: Tuesday, Sept. 15, 2026
Location:
Forum: Fireside Chat and 1x1 Meetings
Morgan Stanley 24th Annual Global Healthcare Conference
Date: Wednesday, Sept. 16, 2026
Location:
Forum: Fireside Chat and 1x1 Meetings
A live webcast of the Morgan Stanley fireside chat will be available in the Investor Relations section of the Company's website at https://ir.enliventherapeutics.com/. A replay of the webcast will be archived on the Company's website for 90 days following the conclusion of the presentation.
About Enliven Therapeutics
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision medicine approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights into clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. To learn more, visit www.enliventherapeutics.com and connect with us on LinkedIn and X.
View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-upcoming-investor-conferences-302869431.html
SOURCE Enliven Therapeutics, Inc.
FAQ
Which investor conferences will Enliven Therapeutics (ELVN) attend in September 2026?
Enliven Therapeutics will participate in three September 2026 healthcare investor conferences: the Wells Fargo 21st Annual Healthcare Conference, the Baird 2026 Global Healthcare Conference, and the Morgan Stanley 24th Annual Global Healthcare Conference.
When and where is the Wells Fargo 21st Annual Healthcare Conference for Enliven Therapeutics (ELVN)?
The Wells Fargo 21st Annual Healthcare Conference featuring Enliven Therapeutics management will be held on Tuesday, September 8, 2026, in Boston, Massachusetts, with participation in 1x1 meetings.
What is the schedule for Enliven Therapeutics (ELVN) at the Baird 2026 Global Healthcare Conference?
At the Baird 2026 Global Healthcare Conference, Enliven Therapeutics will participate on Tuesday, September 15, 2026, in New York, New York, through a fireside chat and 1x1 meetings.
When will Enliven Therapeutics (ELVN) appear at the Morgan Stanley 24th Annual Global Healthcare Conference?
Enliven Therapeutics is scheduled for the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026, in New York, New York, participating in a fireside chat and 1x1 meetings.
How can investors access the Morgan Stanley fireside chat webcast for Enliven Therapeutics (ELVN)?
A live webcast of Enliven Therapeutics’ Morgan Stanley fireside chat will be available in the Investor Relations section of the company’s website at https://ir.enliventherapeutics.com/. A replay will be archived on the site for 90 days after the presentation.